Windlas Biotech Announces Board Restructuring With New Independent Director Appointments
Windlas Biotech Ltd 路 Others (Uncategorized) 路 12 Oct 2026, 11:48 pm
Windlas Biotech Announces Board Restructuring With New Independent Director Appointments Windlas Biotech Limited approved key board changes effective 12th Oct'26. Mr. Vivek Dhariwal resigned as Independent Director and Board Chairman, citing personal reasons. Concurrently, the Board approved the appointments of Mr. Aashish Mehra, possessing over two decades of pharma consulting experience, and Mr. Soni Saran Singh, Founder & MD of NMTronics India, as Additional Independent Directors for five-year terms, subject to shareholder approval.
Original exchange filing (PDF)
More announcements from Windlas Biotech Ltd
- Q2 & H1 FY27 Earnings Conference Call Transcript 路 13 Nov 2026
- Recording of Conference Call 路 07 Nov 2026
- press release titled 'Windlas Biotech Limited Reports its H1 & Q2 FY27 Financial Results" 路 05 Nov 2026
- Mr. Ashok Kumar Windlass, has been appointed, as Founder President (Senior Management Personnel) of the Company, effective from November 6, 2026. 路 05 Nov 2026
- resignation of Mr. Ashok Kumar Windlass (DIN: 00011451) from the position of Whole-time Director and Director of the Company with effect from November 5, 2026 at 10.00 A.M. 路 05 Nov 2026
- Investor Presentation - Q2 & H1FY27, 路 05 Nov 2026
- Windlas Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Approval inter alia unaudited financial results for the quarter and half year ended September 30, 2026 路 05 Nov 2026
